LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

Viatris Inc

Closed

SectorHealthcare

8.28 -2.7

Overview

Share price change

24h

Current

Min

8.26

Max

8.29

Key metrics

By Trading Economics

Income

-2.5B

-3B

Sales

-274M

3.3B

EPS

0.5

Dividend yield

5.48

Profit margin

-93.476

Employees

32,000

EBITDA

-2.7B

-2.3B

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+26.66% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

5.48%

2.41%

Next Earnings

7 sie 2025

Next Dividend date

16 cze 2025

Next Ex Dividend date

22 sie 2025

Market Stats

By TradingEconomics

Market Cap

433M

10B

Previous open

10.98

Previous close

8.28

News Sentiment

By Acuity

50%

50%

153 / 381 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Viatris Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 maj 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Salesforce in Talks to Buy Informatica, Bloomberg Reports, Citing Sources

24 maj 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24 maj 2025, 08:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

24 maj 2025, 07:00 UTC

Earnings

Retailers Are Giving Mixed Messages on Prices. What Will s Really Happen at Checkout. -- Barrons.com

23 maj 2025, 21:57 UTC

Hot Stocks

Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit -- WSJ

23 maj 2025, 21:15 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 maj 2025, 21:04 UTC

Acquisitions, Mergers, Takeovers

Real-Estate Broker Douglas Elliman Could See Takeover Battle After Report of Bid -- Barrons.com

23 maj 2025, 20:56 UTC

Top News
Acquisitions, Mergers, Takeovers

Salesforce Back in Deal Talks With Informatica -- WSJ

23 maj 2025, 20:51 UTC

Top News

Boeing in Tentative Agreement to Pay $1.1 Billion to Avoid Trial for 737 MAX Crashes -- WSJ

23 maj 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23 maj 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 maj 2025, 20:41 UTC

Top News

Stocks Fall on Tariff Broadside, After Week of Bond Market Agita -- WSJ

23 maj 2025, 20:28 UTC

Top News

Trump Threatens EU With 50% Tariffs, Takes Aim at Apple; Nasdaq Drops -- WSJ

23 maj 2025, 20:06 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 5th Update

23 maj 2025, 20:06 UTC

Acquisitions, Mergers, Takeovers

Salesforce Stock Drops, Informatica Soars. A Deal May Be Back on the Table. -- Barrons.com

23 maj 2025, 19:50 UTC

Top News

Trump's Tariffs: Where Things Stand -- 16th Update

23 maj 2025, 19:28 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'Bulk of That Investment Will Occur in the Next 14 Months'

23 maj 2025, 19:28 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'This Will Be a Planned Partnership Between United States Steel and Nippon Steel'

23 maj 2025, 19:27 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'Proud to Announce That, After Much Consideration and Negotiation, US Steel Will REMAIN in America'

23 maj 2025, 19:20 UTC

Market Talk

Crude Futures Post Modest Weekly Losses -- Market Talk

23 maj 2025, 19:18 UTC

Market Talk

U.S. Natural Gas Futures End Week Unchanged -- Market Talk

23 maj 2025, 18:57 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 maj 2025, 18:54 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- Update

23 maj 2025, 18:53 UTC

Top News
Acquisitions, Mergers, Takeovers

McDonald's Bids Goodbye to CosMc's, Its Space Alien-Themed Spinoff -- WSJ

23 maj 2025, 18:52 UTC

Acquisitions, Mergers, Takeovers

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23 maj 2025, 18:13 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23 maj 2025, 18:13 UTC

Market Talk

Gold Trades Higher on Reminder of Risk -- Market Talk

23 maj 2025, 18:00 UTC

Top News

Apple's Stock Still Not Pricing in Trump's Demands - Heard on the Street -- WSJ

23 maj 2025, 17:51 UTC

Market Talk
Earnings

Workday Sees Higher Bar for Guidance -- Market Talk

23 maj 2025, 17:42 UTC

Top News

Dow Drops, Trump Threatens EU With 50% Tariffs, Takes Aim at Apple -- WSJ

Peer Comparison

Price change

Viatris Inc Forecast

Price Target

By TipRanks

26.66% upside

12 Months Forecast

Average 10.5 USD  26.66%

High 13 USD

Low 8 USD

Based on 4 Wall Street analysts offering 12 month price targets forViatris Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

4 ratings

1

Buy

1

Hold

2

Sell

Technical Score

By Trading Central

8.48 / N/ASupport & Resistance

Short Term

Bullish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

153 / 381 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.